Experienced in IgG4-Related Disease

Chao E. Cheng

168 Changhai Road, 
Yangpu, CN 
Experienced in IgG4-Related Disease
168 Changhai Road, 
Yangpu, CN 
OverviewLocationsClinical Research

Overview

Chao Cheng practices in Yangpu, China. Mr. Cheng is rated as an Experienced expert by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Lung Adenocarcinoma, Inflammatory Myofibroblastic Tumor, Lung Cancer, Reconstructive Urology Surgery, and Thymectomy.

His clinical research consists of co-authoring 663 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of IgG4-Related Disease.

Gender
Male

Locations

168 Changhai Road, Yangpu, 200433, China
Other Locations
58 Zhongshan 2nd Road, Guangzhou, 510080, China
2 Zheshan West Road, Wuhu, 241001, China
No. 299 Qing Yang Road, Wuxi, 214023, China
No.1 Xinsi Road, Xi'an, 710038, China
26 Shengli Street, Wuhan, 430030, China
118 North KangFu Road, Yiyang, 413000, China
No.168 Changhai Road, Yangpu, 200433, China
218#Ji Xi Road, Hefei, 230032, China
#79 Qingchun Road, Hangzhou, 310003, China
388 Gaoxin 2nd Road, Wuhan, 430075, China
Block 10, No. 168 In Changhai Road, Yangpu, 200433, China
299 Qingyang Road, Wuxi, 214023, China
28 Fuxing Road, Beijing, 100853, China
Union Hospital, Wuhan, 430022, China
168 Chang Hai Road, Shanghai, 200433, China
No. 87 Xiangya Road, Changsha, 410008, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Multicentre, Prospective, Open Clinical Study of Postoperative ctDNA Dynamic Monitoring and Its Role of Prognosis in Patients With Stage I Non-small Cell Lung Cancer (NSCLC) Using Secondary Gene Sequencing (NGS)
Multicentre, Prospective, Open Clinical Study of Postoperative ctDNA Dynamic Monitoring and Its Role of Prognosis in Patients With Stage I Non-small Cell Lung Cancer (NSCLC) Using Secondary Gene Sequencing (NGS)
Enrollment Status: Completed
Publish Date: September 04, 2024
Intervention Type: Genetic

663 Total Publications

GASPS: A Multi-Omics Framework for Defining Genomic Aberration-Driven Signatures and Predicting Patient Outcomes in Lung Cancer.
GASPS: A Multi-Omics Framework for Defining Genomic Aberration-Driven Signatures and Predicting Patient Outcomes in Lung Cancer.
Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cheng's expertise for a condition
ConditionClose
    View All 17 Advanced Conditions
    View All 98 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile